Connect with us
DAPA Banner

Crypto World

Strategy Buys $1 Billion in Bitcoin, Now Holds 780,897 BTC

Published

on

Strategy Buys $1 Billion in Bitcoin, Now Holds 780,897 BTC

Strategy has acquired 13,927 Bitcoin for approximately $1 billion, pushing its total holdings to 780,897 BTC and cementing its position as the largest corporate Bitcoin holder in the world.

The purchase was executed at an average price of $71,902 per bitcoin, according to an announcement by Executive Chairman Michael Saylor on X. As a result, the latest acquisition brings Strategy’s total Bitcoin investment to $59.02 billion, with a blended average purchase price of $75,577 per coin.

The company now holds approximately 3.8% of Bitcoin’s entire circulating supply. This concentration dwarfs any other publicly traded entity. By comparison, the next largest corporate holder, Twenty One Capital, holds just 43,514 BTC.

Strategy Bitcoin Holdings Need Just 2% Growth to Cover Dividends

Ahead of the purchase, Saylor disclosed a striking financial metric. Strategy’s Bitcoin holdings need to appreciate by just 2.05% annually to cover all preferred stock dividends indefinitely, without issuing new common shares.

“Our BTC Breakeven ARR is approximately 2.05%. If Bitcoin grows faster than that over time, we can cover our dividends indefinitely without issuing new MSTR shares,” Saylor stated.

The company’s dashboard shows approximately 48.7 years of dividend coverage at current reserve levels. This figure underscores the long term sustainability argument Saylor makes for the model. At 2.05%, the threshold sits far below Bitcoin’s historical annualized returns.

Strategy funds its Bitcoin purchases primarily through STRC, its Variable Rate Series A Perpetual Preferred Stock, which currently yields 11.5% annually. The instrument trades near its $100 par value and pays monthly cash dividends. Proceeds directly finance additional Bitcoin acquisitions.

Strategy Continues Buying Despite $14.5 Billion Unrealized Loss

The latest purchase comes despite significant financial headwinds. Strategy reported $14.5 billion in unrealized losses on its digital asset portfolio for Q1 2026. A roughly 20% decline in Bitcoin’s price pushed its value below the company’s average cost basis of $75,577.

Advertisement

Nevertheless, the firm also reported a BTC Yield of 5.6% year to date for 2026. This key performance metric measures the strategy’s effectiveness on a per-share basis.

The acquisition follows Saylor’s now familiar Sunday signal on X, where he posted “Think Bigger” alongside the company’s cumulative BTC purchase chart. This pattern has preceded every major Bitcoin acquisition since 2020 and historically signals a Monday 8K filing disclosing a new purchase.

Strategy Absorbs Three Times More BTC Than Miners Produce

Strategy has made over 105 Bitcoin purchases since beginning its accumulation strategy in August 2020. The company continues buying at a pace that far exceeds new supply.

In March 2026 alone, Strategy absorbed nearly three times the BTC that the entire global mining network produced. Miners generated approximately 16,200 BTC during the month. Strategy acquired 46,233 BTC in the same period.

Advertisement

Meanwhile, remaining at the market offering capacity across all share classes now totals over $57 billion. This provides ample firepower for continued accumulation.

Path to One Million Bitcoin

With this latest purchase, Strategy moves closer to the symbolic threshold of one million Bitcoin. Some analysts project the company could reach this milestone as early as November 2026 if current acquisition rates hold.

At a monthly investment rate of approximately $2.3 billion and BTC prices near current levels, the math supports the projection. However, continued access to capital markets remains essential.

The stock currently trades at approximately 1.10 times its net asset value. This means investors still pay a premium above the underlying Bitcoin holdings. Whether that premium holds depends on Bitcoin’s price trajectory and Strategy’s ability to continue raising capital through its various financing programs.

Advertisement

For now, Saylor’s message remains consistent: think bigger.

The post Strategy Buys $1 Billion in Bitcoin, Now Holds 780,897 BTC appeared first on BeInCrypto.

Source link

Advertisement
Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Crypto World

Allogene Therapeutics (ALLO) Stock Soars 41% Following Breakthrough CAR T-Cell Trial Results

Published

on

ALLO Stock Card

Key Highlights

  • ALPHA3 trial demonstrated 58.3% MRD negativity in cema-cel patients compared to just 16.7% in the observation group
  • Zero instances of cytokine release syndrome or neurotoxicity reported among treated participants
  • Baird analysts upgraded their price target from $7.00 to $9.00 while maintaining Outperform status
  • Probability of success for the therapy program increased to 70% according to Baird’s assessment
  • Shares climbed to $3.87 from $2.91, marking approximately 99% gains year-to-date

Shares of Allogene Therapeutics experienced a dramatic rally exceeding 41% on April 13, 2026, following the disclosure of encouraging interim results from the company’s crucial Phase 2 ALPHA3 clinical study examining cemacabtagene ansegedleucel (cema-cel) in patients diagnosed with high-risk large B-cell lymphoma.


ALLO Stock Card
Allogene Therapeutics, Inc., ALLO

The released information originated from an interim futility analysis conducted on the trial. Within the initial cohort of 24 randomized participants, 58.3% receiving cema-cel treatment successfully achieved minimal residual disease (MRD) negativity. By contrast, the observation group saw merely 16.7% achieve this benchmark — representing a substantial 41.6 percentage point advantage.

Researchers are utilizing Natera’s investigational CLARITY MRD assay to detect high-risk patients prior to observable clinical relapse. The study positions cema-cel as a first-line consolidation treatment option, which would represent an earlier intervention point than most existing CAR T therapeutic strategies.

Remarkable Safety Results Generate Buzz

The trial’s safety outcomes proved equally compelling as the effectiveness data. Remarkably, no treated participants developed cytokine release syndrome or immune effector cell-associated neurotoxicity syndrome — two complications frequently linked with CAR T cellular therapies.

Additionally, zero treatment-related serious adverse events were documented. Such a clean safety profile stands out significantly within this therapeutic category, prompting Baird analysts to highlight it as a key distinguishing characteristic when evaluating cema-cel against second-line autologous CAR T alternatives.

Advertisement

The therapy’s potential for outpatient administration, coupled with these favorable safety metrics, contributes to what could be a distinctive competitive position. Current CAR T treatments typically mandate inpatient care and are associated with more substantial toxicity concerns.

Following the data announcement, Baird elevated its ALLO price objective from $7.00 to $9.00 while retaining its Outperform recommendation. The investment firm also boosted its probability of success projection for this therapeutic program to 70%.

“The limited dataset size of 12 treated patients should generate enthusiasm,” Baird wrote, acknowledging the early-stage nature of the readout while flagging the initial results as a positive signal for the commercial profile in the first-line setting.

Looking Forward

The ALPHA3 clinical study is recruiting approximately 220 participants across more than 60 clinical sites. Efficacy endpoints continue to remain blinded currently, and the available dataset remains relatively limited. These preliminary figures will require validation as additional trial data matures.

Scheduled interim event-free survival analyses are anticipated in 2027, with complete primary results projected for 2028. Favorable outcomes from these assessments could potentially support a future biologics license application submission.

Advertisement

Additional Wall Street analysts are monitoring developments closely. Jefferies recently launched coverage on ALLO with a Buy recommendation and a $6.00 price objective, while Citizens maintained its Market Outperform stance with a $5.00 target price.

ALLO shares reached $3.87 on April 13, advancing from the previous session’s close of $2.91. The equity has gained approximately 99% year-to-date and is currently trading near its 52-week peak. InvestingPro analysis indicates the stock is presently valued above its calculated fair value, though the biotechnology company maintains a balance sheet with cash holdings exceeding debt obligations.

Source link

Advertisement
Continue Reading

Crypto World

Broadcom (AVGO) Stock Surges on Extended Google Partnership and Raised AI Revenue Projections

Published

on

AVGO Stock Card

Key Takeaways

  • UBS maintained its Buy recommendation with a $475 price objective for Broadcom (AVGO) following an extended Google collaboration lasting until 2031
  • The expanded agreement includes next-generation TPU systems and networking infrastructure, granting Anthropic access to approximately 3.5GW of TPU compute capacity starting 2027
  • TPU order projections tied to Anthropic have climbed to roughly $50 billion from approximately $40 billion spanning 2026–2027
  • UBS increased Broadcom’s fiscal 2027 AI revenue projection to $145 billion from a previous $133 billion estimate
  • Wall Street responses varied — Seaport Global shifted AVGO to Neutral while Mizuho and BofA Securities retained bullish stances

Broadcom (AVGO) has secured a comprehensive multi-year arrangement with Google extending into 2031, capturing significant attention from financial analysts. This expanded partnership encompasses upcoming TPU technology iterations alongside networking infrastructure and rack-level systems — representing a substantial deepening of an already critical client relationship.


AVGO Stock Card
Broadcom Inc., AVGO

The arrangement also integrates Anthropic into the equation. Beginning in 2027, the artificial intelligence firm is positioned to receive approximately 3.5GW worth of TPU-powered computational resources, contingent upon sustained commercial expansion. This substantial commitment rapidly influenced analyst financial modeling.

UBS analyst Timothy Arcuri maintained his Buy position with a $475 price objective following the announcement. He characterized the developments as “incremental to the near-term TPU risk debate,” while anticipating investor attention will pivot toward ASIC diversification beyond TPU technology as MediaTek accelerates manufacturing.

The updated UBS projections carry significant weight. Anthropic-connected TPU orders for Broadcom now approach $50 billion, representing an increase from the approximately $40 billion estimated across calendar years 2026 and 2027 under previous assumptions.

UBS currently projects Broadcom will deliver approximately 7 million TPU units during calendar year 2027, elevated from an earlier 6 million unit forecast. This single adjustment underscores the magnitude of the partnership.

Advertisement

Top-Line Projections Move Higher

Regarding overall revenue expectations, UBS elevated its FY2027 projection to $195 billion from $182 billion. Its calendar 2027 estimate advanced to $212 billion from $195 billion.

AI-specific revenue for fiscal 2027 now stands at $145 billion compared with the prior $133 billion estimate. This projection already exceeds Broadcom’s internal guidance considerably.

Broadcom has achieved a 77% gross profit margin alongside 25% revenue expansion over the trailing twelve months, per InvestingPro analytics. The company’s market capitalization currently stands at $1.76 trillion.

Billionaire investor Ken Fisher maintains a $4.79 billion position in AVGO, positioning it as his eighth-largest AI equity holding. Fisher’s investment rationale emphasizes Broadcom’s capability to develop customized, application-specific chips that general-purpose GPUs cannot effectively duplicate.

Advertisement

Wall Street Opinion Diverges

Not all analysts share the optimistic view. Seaport Global Securities lowered AVGO from Buy to Neutral, citing broader AI sector limitations despite Broadcom’s strong competitive positioning.

Mizuho maintained its Outperform designation with a $480 price objective. BofA Securities similarly preserved its Buy rating, establishing a $450 target. Both institutions cited the Google and Anthropic arrangements as primary drivers supporting their constructive outlooks.

D.A. Davidson retained a Neutral stance with a $375 price target, while emphasizing the strategic importance of Broadcom’s extended Google partnership for customized AI silicon.

On the product development front, Broadcom recently introduced Arcot Smart Ruleset this month — a machine learning-powered fraud prevention platform designed to enhance 3-D Secure payment verification by automating fraud detection logic that historically required manual configuration.

Advertisement

The TPU partnership with Google, guaranteeing supply continuity for networking and rack-level infrastructure through 2031, remains the primary catalyst behind revised analyst financial models.

Source link

Advertisement
Continue Reading

Crypto World

ECB Sets Cautious Path for Tokenized Capital Markets in New Bulletin

Published

on

Legislation, ECB, European Union, Stablecoin, Tokenization, RWA Tokenization

The European Central Bank (ECB) set out a cautious path toward tokenizing Europe’s capital markets, saying the technology can deliver efficiency gains only if it remains anchored to central bank money, infrastructures remain interoperable, and regulation is “robust and supportive.” 

In its latest Macroprudential Bulletin published on Monday, the ECB said distributed ledger technology (DLT) could help deepen the European Union’s savings and investments union, but warned that benefits will depend on interoperable infrastructure and policymakers keeping pace with new risks. 

The central bank’s stance highlights a push to modernize market plumbing in the bloc without loosening control over settlement or financial stability.

The ECB said that tokenization and DLT are “moving from concept to early-scale deployment,” but the benefits will “only be realised safely if European policy action keeps pace.”

Advertisement

ECB maps conditions for tokenized capital markets

One article in the Bulletin lays out how tokenized assets could rewire the issuance-to-settlement chain, cutting operational frictions and potentially improving secondary market liquidity. By moving securities and cash onto compatible ledgers and automating corporate actions, the authors argue, tokenization could streamline processes that today rely on multiple intermediaries and legacy systems. 

Legislation, ECB, European Union, Stablecoin, Tokenization, RWA Tokenization
Digital assets landscape. Source: ECB

The analysis underlines, however, that efficiency gains hinge on avoiding a patchwork of incompatible platforms and ensuring that central bank money, not just commercial bank money or privately issued tokens, can be used for settlement in tokenized markets.

Related: EU central bank backs plan for crypto supervision under EU markets watchdog

A further piece drills into the nascent market for tokenized bonds, finding early evidence that they can already lower borrowing costs and tighten bid-ask spreads compared with traditional formats. 

The authors attribute this partly to operational efficiencies and partly to improved transparency and programmability around settlement and collateral management. Still, they frame these benefits as tentative and conditional, cautioning that technology, legal and liquidity risks remain and that policymakers will need to monitor whether advantages persist once tokenization scales beyond flagship deals and highly selected issuers.

Advertisement

Tokenized MMFs and euro stablecoins under the microscope

The Bulletin also takes a hard look at tokenized money market funds and euro-denominated stablecoins, treating them as parallel experiments in onchain cash-like instruments.

One article stresses that tokenized money market funds (MMFs) largely replicate familiar liquidity and run risks but layer on new operational vulnerabilities, raising questions about how they would behave under stress alongside stablecoins.

Legislation, ECB, European Union, Stablecoin, Tokenization, RWA Tokenization
Comparison between balance sheet and asset-backed model. Source: ECB

Another argues that Markets in Crypto-Assets Regulation (MiCA) compliant euro stablecoins could reshape demand for sovereign bonds and act either as a liquidity buffer in turbulent markets or a new channel of bank contagion, depending on how issuers meet deposit and reserve requirements. 

Across the five pieces in the Bulletin, the ECB’s stance is clear: Tokenization can support its vision of an integrated capital market, but only if policy, prudential rules and central bank infrastructure evolve in lockstep.

Cointelegraph reached out to the ECB for comment, but had not received a response by publication.

Advertisement

Magazine: Asia Express: Phantom Bitcoin checks, China tracks tax on blockchain